Cibus, Inc. is classed by the SEC under Agricultural Chemicals (industry code 2870), based in San Diego, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $4 million and a loss of $132 million (its filed statements).
Product businessAgricultural ChemicalsSan Diego, CAfilings since 20178 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2870, Agricultural Chemicals); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 3.6 out of ten, 8 of 9 metrics filed and 1 estimated: past 3.3 out of ten, present 2.2 out of ten, future 5.6 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 3.8 out of ten. 3 warning events since 2017; the latest 2023-06-01. 38th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 4.0 out of ten. +27.8% a year over 10 filed years; profitable in 0 of 10. 40th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 1.4 out of ten. CrossAssetData estimate 1.4/10, confidence 35 of 100 (one part). 14th percentile among 11 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Financial health (present): 1.2 out of ten. ROE -582%: lost 582¢ per shareholder dollar. Leverage 93%: owes 93¢ per asset dollar. 12th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 3.8 out of ten. bottom 38% of 11 in its family; net margin -3492.3%. 38th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 1.9 out of ten. bottom 19% of 7 in its family for leadership; chief executive since 2026. 19th percentile among 7 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 5.4 out of ten. top 46% of 11 in its family for room to expand. 54th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 5.7 out of ten. top 43% of 11 in its family for growth drivers. 57th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 5.9 out of ten. top 41% of 11 in its family for expectations against reality. 59th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-03-17 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-13 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-13 (on EDGAR). Newest filing: Form 10-Q, 2026-08-13. Filings on record since 2017. Read from EDGAR 2026-10-12.
Who runs it
Wichner, Craig (CEO); Riggs, Rory B (Chief Executive Officer); Beetham, Peter (Interim CEO, Pres & COO); Broos, Carlo (CFO); Gocal, Gregory Francis William (Chief Scientific Officer & EVP); Sauer, Noel (Sr VP, Research); Stokes, Jason (CAO, Gen Csl & Corp Secy); Box, Kimberly Ann (director); Finn, Mark Terrence (director); Lehmann, Jean-Pierre Jules (director); and 3 more. 13 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.